East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Metronidazole Topical Cream, 0.75%. Aurobindo Pharma’s Metronidazole Topical Cream, are an AB-rated generic equivalent to the reference listed drug (RLD), MetroCream Topical Cream manufactured by Galderma Laboratories, L.P.

Metronidazole Topical Cream are indicated for:

• Topical application in the treatment of inflammatory papules and pustules of rosacea.